azacitidine and Nasopharyngeal Carcinoma

azacitidine has been researched along with Nasopharyngeal Carcinoma in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	10 (90.91)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Chen, W; Liu, H; Zhang, W; Zhang, Y	1
Bossi, P; Chen, P; Haddad, RI; Hansen, AR; Hsieh, CY; Licitra, LF; Mesia, R; Miller, J; Siu, LL; Tan, EH	1
Liu, J; Liu, W; Luo, B; Wang, J; Zhao, Z	1
Gong, P; Li, J; Li, X; Lyu, X; Peng, H; Yao, K	1
Allaya, N; Ayadi, W; Daoud, J; Frikha, H; Frikha, M; Gargouri, A; Ghorbel, A; Khabir, A; Mokdad-Gargouri, R; Trigui, E	1
Claret, FX; Wang, S; Yang, H; Zhang, R	1
Liu, ZH; Luo, FY; Tang, CE; Xiao, S; Xiao, ZQ; Zhang, PF	1
Almgren, M; Du, ZM; Ernberg, I; Hu, LF; Ignatyev, I; Kashuba, V; Moumad, K; Nawaz, I; Pavlova, TV; Zabarovsky, ER	1
Chan, JY; Ho, WK; Man, OY; To, VS; Tsang, CM; Tsang, RK; Tsao, SW; Wei, WI; Wong, TS	1
Chan, SH; Chen, H; Cheung, FM; Chiu, PM; Chua, D; Hyytiainen, M; Kan, R; Keski-Oja, J; Ko, JM; Kwong, DL; Lee, AW; Lung, ML; Nicholls, JM; Stanbridge, EJ; Tao, Q; Tsao, SW; Wong, VC; Zabarovsky, ER	1
He, G; Li, H; Li, W; Ma, Y; Tan, G; Zhang, X	1

Trials

1 trial(s) available for azacitidine and Nasopharyngeal Carcinoma

Article	Year
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma. European journal of cancer (Oxford, England : 1990), 2019, Volume: 123 Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Asian People; Azacitidine; Chemotherapy-Induced Febrile Neutropenia; Disease-Free Survival; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Native Hawaiian or Other Pacific Islander; Neoplasm Recurrence, Local; Neutropenia; Progression-Free Survival; White People	2019

Article

Year

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma.

European journal of cancer (Oxford, England : 1990), 2019, Volume: 123

Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Asian People; Azacitidine; Chemotherapy-Induced Febrile Neutropenia; Disease-Free Survival; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Native Hawaiian or Other Pacific Islander; Neoplasm Recurrence, Local; Neutropenia; Progression-Free Survival; White People

2019

Other Studies

10 other study(ies) available for azacitidine and Nasopharyngeal Carcinoma

Article	Year
TMEM130 regulates cell migration through DNA methylation in nasopharyngeal carcinoma. Cancer biomarkers : section A of Disease markers, 2022, Volume: 34, Issue:2 Topics: Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA, Messenger	2022
The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. Journal of medical virology, 2017, Volume: 89, Issue:10 Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Genes, APC; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Repressor Proteins; Stomach Neoplasms	2017
Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. Oncology reports, 2014, Volume: 31, Issue:5 Topics: Azacitidine; Base Sequence; Biomarkers, Tumor; Carcinoma; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; PTEN Phosphohydrolase; RNA, Messenger; Sequence Analysis, DNA	2014
Identification of a novel methylated gene in nasopharyngeal carcinoma: TTC40. BioMed research international, 2014, Volume: 2014 Topics: Animals; Azacitidine; Carcinoma; Cell Line, Tumor; CpG Islands; Cytoskeletal Proteins; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Proteins; Promoter Regions, Genetic; Proteins; Xenograft Model Antitumor Assays	2014
Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Molecular cancer therapeutics, 2014, Volume: 13, Issue:12 Topics: Animals; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Mice; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Tumor Burden; Xenograft Model Antitumor Assays	2014
Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytoskeletal Proteins; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Tumor Suppressor Proteins	2015
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. Oncotarget, 2015, Oct-13, Volume: 6, Issue:31 Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Carcinoma; Case-Control Studies; Cell Proliferation; Cells, Cultured; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha Chains; Integrins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Wnt Proteins	2015
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:3 Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation	2011
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. Cancer letters, 2012, Dec-01, Volume: 325, Issue:1 Topics: Azacitidine; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Latent TGF-beta Binding Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Promoter Regions, Genetic; Tumor Microenvironment; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A	2012
Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. Anti-cancer drugs, 2012, Volume: 23, Issue:8 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Profiling; Genomics; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel	2012